Pure Global

Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection

Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection is a medical device type in the Unknown specialty. This page includes real-world medical device registration data worldwide for this device type, with registrations from US FDA, Brazil ANVISA, and other global markets. This device type includes life-sustaining products.

View regulatory classifications, recent 510(k) clearances, active device registrations, and similar products registered globally under this device category. Pure Global AI's free directory provides comprehensive worldwide registration intelligence across 7,000+ medical device types and 21 specialties.

Global Registration Data
Multi-Country Intelligence
Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection
Unknown Medical Device Type
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Regulatory Classifications

US Regulatory Classifications

OCB

View Product Code Classification

Class 3

21 CFR

View CFR Regulation

Unknown

Device Characteristics

No

No

Yes

Not Eligible

Definition

A gene expression test for detection of cancer metastasisis an in vitro diagnostic test performed on tissue of interest from patients previously diagnosed with cancer. Results from the test can be used to guide the intra-operative or post-operative decision to remove additional tissue. Post-operative histological evaluation of permanent sections of the tissue specimen, in accordance with usual diagnostic practice and using an appropriate histological sampling scheme, is required.